CALML4

Across TCGA pan-cancer cohorts, CALML4 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CALML4 data layer compared with 29 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher CALML4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CALML4 expression acts as an unfavorable survival marker.

HNSC and SKCM are the cancer types where CALML4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.152	0.768	<.001	48	view →
SKCM	OS	Median	II,III,IV	0.072	0.843	<.001	24	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CALML4–HNSC (OS)

Open the HNSC breakdown →